The company was a resident at the gate from July 2020 to December 2022.

Using AI-powered MRI, Orbem delivers non-invasive insights into a diverse range of biology. By transforming what is becoming the world’s largest biological dataset into actionable intelligence, Orbem helps food producers, researchers, and innovators make better decisions. Orbem’s rapid, nondestructive analyses reduce waste, increase quality and transparency, and accelerate the shift toward a more sustainable and healthier future.

Company details:

• Lead investor: Innovation Industries
• Team members: 200+
• Funding round: Series B
• Announcement date: January 20, 2026
• Amount raised: €55.5m

Contact:
Web: orbem.ai
LinkedIn: ORBEM